Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC

SIMPLE SUMMARY: The prognostic evaluation and therapeutic management of hepatocarcinoma (HCC) is based on the Barcelona Liver Cancer Clinic (BCLC). In the past years, immunotherapy has become a mainstay of first-line treatment in advanced HCC and further treatment options are underway. Beyond this,...

Descripción completa

Detalles Bibliográficos
Autores principales: Marzi, Luca, Mega, Andrea, Gitto, Stefano, Pelizzaro, Filippo, Seeber, Andreas, Spizzo, Gilbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313349/
https://www.ncbi.nlm.nih.gov/pubmed/35884392
http://dx.doi.org/10.3390/cancers14143332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313349/
https://www.ncbi.nlm.nih.gov/pubmed/35884392
http://dx.doi.org/10.3390/cancers14143332

Ejemplares similares